Loading clinical trials...
Loading clinical trials...
Retrospective study to evaluate the effect of a remote cognitive-rehabilitative intervention during the Covid outbreak in subjects with Parkinson's disease.
Mild cognitive impairment is frequent among people with Parkinson's disease. Cognitive training seems effective on cognitive status and for mitigating anxiety and depression. With COVID-19 outbreak, such therapeutic interventions were delivered online. This retrospective study was aimed at evaluating the effectiveness of an online cognitive treatment, carried out in COVID times and based on the Parkinson's-Adapted Cognitive Stimulation Therapy, on cognitive domains and mood in 18 older people with Parkinson's disease.
Age
All ages
Sex
ALL
Healthy Volunteers
No
IRCCS INRCA Hospital
Ancona, Italy
Start Date
January 1, 2020
Primary Completion Date
October 31, 2020
Completion Date
October 31, 2020
Last Updated
July 27, 2022
18
ACTUAL participants
Cognitive digital treatment
OTHER
Lead Sponsor
Istituto Nazionale di Ricovero e Cura per Anziani
NCT07220668
NCT07221162
NCT04246437
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions